These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 21834774)

  • 1. Oral fast-release solid dispersion-paradigm shift to nanoparticles.
    Wong TW
    Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):227-43. PubMed ID: 21834774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances and patents in solid dispersion technology.
    Iqbal B; Ali A; Ali J; Baboota S; Gupta S; Dang S; Shadab M; Sahni JK
    Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):244-64. PubMed ID: 21834778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Overview on Recent Patents and Technologies on Solid Dispersion.
    Kaushik R; Budhwar V; Kaushik D
    Recent Pat Drug Deliv Formul; 2020; 14(1):63-74. PubMed ID: 31951172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical solid dispersion technology: a strategy to improve dissolution of poorly water-soluble drugs.
    Kumar S; Gupta SK
    Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):111-21. PubMed ID: 23331062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances and patents on solid lipid nanoparticles.
    Sawant KK; Dodiya SS
    Recent Pat Drug Deliv Formul; 2008; 2(2):120-35. PubMed ID: 19075903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubilization of poorly water-soluble drugs using solid dispersions.
    Tran TT; Tran PH; Khanh TN; Van TV; Lee BJ
    Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):122-33. PubMed ID: 23244679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid nanoparticles for the delivery of poorly water-soluble drugs.
    Bunjes H
    J Pharm Pharmacol; 2010 Nov; 62(11):1637-45. PubMed ID: 21039547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
    Meng F; Gala U; Chauhan H
    Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionally engineered nanosized particles in pharmaceutics: improved oral delivery of poorly water-soluble drugs.
    Ozeki T; Tagami T
    Curr Pharm Des; 2013; 19(35):6259-69. PubMed ID: 23470003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivery strategies for poorly water-soluble drugs.
    Fahr A; Liu X
    Expert Opin Drug Deliv; 2007 Jul; 4(4):403-16. PubMed ID: 17683253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
    Bikiaris DN
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1501-19. PubMed ID: 21919807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid dispersions: a strategy for poorly aqueous soluble drugs and technology updates.
    Alam MA; Ali R; Al-Jenoobi FI; Al-Mohizea AM
    Expert Opin Drug Deliv; 2012 Nov; 9(11):1419-40. PubMed ID: 23043303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid lipid nanoparticles for encapsulation of hydrophilic drugs by an organic solvent free double emulsion technique.
    Becker Peres L; Becker Peres L; de Araújo PHH; Sayer C
    Colloids Surf B Biointerfaces; 2016 Apr; 140():317-323. PubMed ID: 26764112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative Manufacturing Concepts for Solid Oral Dosage Forms From Drug Nanosuspensions Using Fluid Dispensing and Forced Drying Technology.
    Bonhoeffer B; Kwade A; Juhnke M
    J Pharm Sci; 2018 Mar; 107(3):909-921. PubMed ID: 29154900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug nanoparticles: formulating poorly water-soluble compounds.
    Merisko-Liversidge EM; Liversidge GG
    Toxicol Pathol; 2008 Jan; 36(1):43-8. PubMed ID: 18337220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical Amorphous Nanoparticles.
    Jog R; Burgess DJ
    J Pharm Sci; 2017 Jan; 106(1):39-65. PubMed ID: 27816266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocarriers for oral drug delivery.
    Zhang L; Wang S; Zhang M; Sun J
    J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticulate strategies for effective delivery of poorly soluble therapeutics.
    Gokce EH; Ozyazici M; Souto EB
    Ther Deliv; 2010 Jul; 1(1):149-67. PubMed ID: 22816125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hot Melt Extruded and Injection Moulded Dosage Forms: Recent Research and Patents.
    Major I; McConville C
    Recent Pat Drug Deliv Formul; 2015; 9(3):194-200. PubMed ID: 27165308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanosuspensions in drug delivery: recent advances, patent scenarios, and commercialization aspects.
    Chavhan SS; Petkar KC; Sawant KK
    Crit Rev Ther Drug Carrier Syst; 2011; 28(5):447-88. PubMed ID: 22077201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.